Recurrent Esthesioneuroblastoma: Long-Term Outcomes of Salvage Therapy.

Garrett NiCarlos D Pinheiro-NetoEhiremen IyohaJamie J Van GompelMichael J LinkMaria Peris-CeldaEric J MooreJanalee K StokkenMauricio GamezGarret W Choby G

Published in: Cancers (2023)

Following an ENB recurrence, salvage therapy appears to be an effective therapeutic option with a subsequent 5-year OS of 63%. However, subsequent recurrences are not infrequent and may require additional therapy.

Keyphrases

replacement therapy